Health Affairs March 1, 2024
Geoffrey Joyce, Barbara Blaylock, Jiafan Chen, Karen Van Nuys

Abstract

Drug utilization management tools can be employed to ensure that medicines are prescribed cost-effectively, but they can also be implemented in ways that reduce adherence and harm patient health. We examined trends in the prevalence of utilization restrictions on non-protected-class compounds in Medicare Part D plans during the period 2011–20, including prior authorization and step therapy requirements as well as formulary exclusions. Part D plans became significantly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Medicare Advantage, Patient / Consumer, Provider
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
ACOs Saved Billions in 2023: Can They Sustain This Beyond 2025?
Telehealth under threat: Why Congress must act to save Medicare coverage [PODCAST]
Biden’s Healthcare Legacy: A 2024 Year-End Review
Inflation Reduction Act Medicare changes taking effect in 2025: 5 things to know

Share This Article